NCCN Clinical Practice Guidelines in Oncology: myelodysplastic syndromes.

Overview of attention for article published in Journal of the National Comprehensive Cancer Network (JNCCN), January 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

patent: 6 patents

guideline: 1 clinical guideline source

Readers on

mendeley: 11 Mendeley

So far, Altmetric has seen 6 patents that reference this research output.

Methods and compositions for treating myelofibrosis

Grant US-12194076-B2

United States of America

14 Jan 2025

Activin-ActRII antagonists and uses for treating anemia

Grant US-11471510-B2

United States of America

18 Oct 2022

Methods for treating myelodysplastic syndromes and sideroblastic anemias

Grant US-10829531-B2

United States of America

10 Nov 2020

Activin-ActRII antagonists and uses for treating bone and other disorders

Grant US-10195249-B2

United States of America

05 Feb 2019

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 2 additional patents.